chronic inflammatory diseases

Le spondiloartropatie giovanili

Ballaben A, Vrinceanu A, Pastore S, Taddio A.

2025/9 — pag. 563-567 — DOI

Juvenile spondyloarthropathies (JSpA) are a heterogeneous group of chronic inflammatory diseases, including enthesitis-related arthritis (ERA), juvenile psoriatic arthritis (JPsA) and undifferentiated arthritis. Many clinical features overlap with ot...

I farmaci delle malattie infiammatorie cronicheFANS, steroidi, talidomide: gli inibitori della fase finaledella cascata infiammatoria

G. Gortani, A. Tommasini, G. Di Leo, L. Lepore

2008/6 — pag. 381-387

The article describes the medications that are used to treat chronic inflammatory disorders, and that act by inhibition of production of harmful substances. It presents the mechanism of action of NSAIDs, glucocorticoids and thalidomide, their side ...

I farmaci delle malattie infiammatorie croniche: dall’empirismo alla medicina molecolare

Giulia Gortani, Erica Valencic, Alberto Tommasini, Loredana Lepore

2007/6 — pag. 381-385

Chronic inflammatory diseases still represent a very dramatic problem in pediatric age. Therapeutic strategies are improving very quickly, but a complete control of disease progression is still a challenge. In a series of articles we try to address a...

Il Pneumocisti Carinii

M. Lazzerini

2004/11

I probiotici in gastroenterologia pediatrica: evidenze cliniche

M. Fontana, L. Martelli

2004/3 — pag. 175-182

Probiotics are dietary supplements made of live micro-organisms which improve the microbial environment of the gut. Out of 16 randomized controlled trials (RCTs) 11 showed positive results on the duration of the diarrhoea, although there are no dat...